AZA-1

Unknown Manufacturer

Generate AI report

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Showing the 100 most relevant patent families.

PROCESS FOR THE PREPARATION OF (R)-3-(6-(4-METHYLPHENYL)-PYRIDIN-3-YLOXY)-1-AZA-BICYCLO[2.2.2]OCTANE BY REACTING 5-CHLORO-2-(4-METHYLPHENYL)PYRIDINE WITH (R)-3-HYDROXY-1-AZA-BICYCLO[2.2.2]OCTANE
EP 3075732 B1Applicant: NOVARTIS AGPriority: 2011
CN
EP
US
WO
12 publications
AZA-ARYL 1H-PYRAZOL-1-YL BENZENE SULFONAMIDES AS CCR(9) ANTAGONISTS
EP 3263564 B1Applicant: CHEMOCENTRYX INCPriority: 2012
EP
US
10 publications
[(1H-indol-5-yl)-heteroaryloxy]-1-aza-bicylco[3.3.1]nonanes as cholinergic ligands of the n-AChR for the treatment of psychotic and neurodegenerative disorders
US 7713976 B2Applicant: NOVARTIS AGPriority: 2005
EP
US
8 publications
1-Aza-Bicyclo3.3.1Nonanes
US 2007249657 A1Applicant: FEUERBACH DOMINIKPriority: 2004
CN
EP
US
6 publications
3-(Heteroaryl-Oxy)-2-Alkyl-1-Aza-Bicycloalkyl Derivatives As Alpha. 7-Nachrligands For TheTreatment Of Cns Diseases
US 2008194573 A1Applicant: NOVARTIS AGPriority: 2004
CN
EP
US
6 publications
Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-6H-5-oxa-1-aza-phenanthrene
US 6903110 B2Applicant: WYETH CORPPriority: 2002
US
6 publications
Aza-indoles and related compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity
US 8012992 B2Applicant: ALLERGAN INCPriority: 2009
US
6 publications
(1-aza-bicyclo[3.3.1]non-4-yl)-[5-(1H-indol-5-yl)-heteroaryl]-amines as cholinergic ligands of the n-achr for the treatment of psychotic and neurodegenerative disorders
US 7713977 B2Applicant: NOVARTIS AGPriority: 2005
CN
EP
US
5 publications
3-amino-1-arylpropyl indoles and aza-substituted indoles and uses thereof
US 7446118 B2Applicant: ROCHE PALO ALTO LLCPriority: 2006
CN
US
5 publications
PHARMACEUTICAL DOSAGE FORMS COMPRISING (4S)-24-CHLORO-4-ETHYL-73-FLUORO-35-METHOXY-32,5- DIOXO-14-(TRIFLUOROMETHYL)-32H-6-AZA-3(4,1)-PYRIDINA-1(1)-[1,2,3]TRIAZOLA-2(1,2),7(1)- DIBENZENAHEPTAPHANE-74-CARBOXAMIDE
EP 4304561 A1Applicant: BAYER AGPriority: 2021
CN
EP
US
WO
4 publications

Drugs